CD4-positive helper T cell activation via antigen presentation

"CD4-positive helper T cell activation via antigen presentation" refers to the complex immune process by which naive CD4+ helper T cells are activated through specific recognition of peptide antigens presented by major histocompatibility complex class II (MHCII) molecules on antigen-presenting cells (APC), along with co-stimulatory signals such as CD28-CD80/CD86 interaction. This activation is essential for generating effective adaptive immune responses, B cell help, cytokine production, and differentiation into effector subsets such as Th1, Th2, Th17, and Treg. The process is tightly regulated by additional co-stimulatory and co-inhibitory receptors (e.g., CTLA-4, PD-1), and is a critical focal point for both therapeutic immune activation (such as in cancer immunotherapy) and immunosuppression (such as in transplantation or autoimmune diseases)[1][2][3][4][6][7].

Other names

CD4+ T cell activationHelper T cell activationT helper lymphocyte activation

Inhibition of co-stimulatory signaling (e.g., CTLA-4-Ig prevents CD28-CD80/CD86 interaction) - Immune checkpoint blockade (inhibiting CTLA-4 or PD-1 to enhance activation)